tirzepatide trump President unveils deal to expand coverage and lower costs on weight loss drugs tirzepatide | Woman's World

Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year

On the other hand, L-Carnitine 3000 is for people who want a stronger dose

That is still dramatically cheaper than brand-name tirzepatide at retail prices of $1,069 per month

These drugs have other uses, too

P = 0.02) and in SELECT trial (HR 0.80

It is included on the 2026 WADA Monitoring Program alongside semaglutide, allowing WADA to gather data on GLP-1 receptor agonist use patterns ahead of a possible Prohibited List decision by late 2026 or 2027